We have not finalised the choice of indications for the Phase 2 study yet. That will be further informed by the two weekly dose escalation study that we have now started.
It's not approval though as they later told us. You just tell the FDA what you are doing, carry on and if the FDA decide they don't like it they tell you to stop .
So the fact there is no rns stating the FDA called a halt to it is actually positive.